Microbiology & Virology

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

My lab: Clinical microbiology service

Senior Biomedical Scientist James Griffiths gives a guided tour of his lab at the Royal Cornwall Hospital in Truro.

Tech news: March 2024

This month's top tech news stories

Iodine antiseptic and surgical-site infections

A large multicentre clinical trial found that an antiseptic containing iodine resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic.

Point-of-care testing

Point of Care Project Manager Rakhee Surti outlines a unique project to enhance patient health outcomes in the community.

Mitochondria, fatigue and long COVID

Persistent fatigue in patients with long COVID has a biological cause – mitochondria in muscle cells that produce less energy than in healthy patients.

Influenza A(H1N2)V

Claire Atkinson, a Lecturer in Biomedical Science at London South Bank University, on the recent detection of influenza A(H1N2).

Top